Richard D Harvey

Dr. Richard D Harvey

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
OPOlivia Pabois
Olivia Pabois
RZRobert M. Ziolek
Robert M. Ziolek
CLChristian D. Lorenz
Christian D. Lorenz
Sylvain François PrevostSylvain François Prevost
Sylvain François Prevost
NMNajet Mahmoudi
Najet Mahmoudi
CDCecile Dreiss
Cecile Dreiss

1 October 2018 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
MHMireille Hassoun
Mireille Hassoun
Paul RoyallPaul Royall
Paul Royall
MPMark Parry
Mark Parry
RHRichard D Harvey
Richard D Harvey
BFBen Forbes
Ben Forbes
Biorelevant fluids are required to enable meaningful in vitro experimental determinations of the biopharmaceutical properties of inhaled medicines, e.g. drug solubility, particle dissolution, cellular uptake. Our aim was to develop a biorelevant simulated lung fluid (SLF) with a well-defined composition and evidence-based directions for use. The SLF contained dipalmitoylphosphotidylcholine, dipalmitoylphosphatidylglycerol, cholesterol, albumin, IgG, transferrin and antioxidants. Freshly made SLF had pH 7.2, viscosity 1.138 × 10−3 Pa s, conductivity 14.5 mS/m, surface tension 54.9 mN/m and density 0.999 g/cm3. Colour, surface tension and conductivity were the most sensitive indicators of product deterioration. The simulant was stable for 24 h and 48 h at 37 °C and 21 °C, respectively, (in-use stability) and for 14 days when stored in a refrigerator (storage stability). To extend stability, the SLF was vacuum freeze-dried in batches to produce lyophilised powder that can be reconstituted readily when needed at the point of use. In conclusion, we have reported the composition and manufacture of a biorelevant, synthetic SLF, provided a detailed physico-chemical characterisation and recommendations for how to store and use a product that can be used to generate experimental data to provide inputs to computational models that predict drug bioavailability in the lungs.

13 February 2017 in Biochemistry
Verified
Journal Article
Closed access
AHAlasdair Hubbard
Alasdair Hubbard
RBRobert Barker
Robert Barker
RRReg Rehal
Reg Rehal
KVKalliopi-Kelli A. Vandera
Kalliopi-Kelli A. Vandera
RHRichard D Harvey
Richard D Harvey
ACAnthony Coates
Anthony Coates

1 August 2017 in Chemistry and Physics of Lipids
Verified
Journal Article
Open access
RRReg P. Rehal
Reg P. Rehal
HMHelene Marbach
Helene Marbach
AHAlasdair Hubbard
Alasdair Hubbard
ASAnam A. Sacranie
Anam A. Sacranie
FSFederica Sebastiani
Federica Sebastiani
RHRichard D Harvey
Richard D Harvey
The increased biosynthesis of lysyl-phosphatidylglycerol in Staphylococcus aureus when cultured under conditions of mild acidity and the resultant increased proportion of this lipid in the plasma membrane of the bacterium, alters the physico-chemical properties of lipid bilayers in a manner which is itself dependent upon environmental pH. Clinically relevant strains of S. aureus, both methicillin susceptible and resistant, all exhibited increased lysyl-phosphatidylglycerol biosynthesis in response to mild environmental acidity, albeit to differing degrees, from ∼30% to ∼55% total phospholipid. Polar lipid extracts from these bacteria were analysed by 31P NMR and reconstituted into vesicles and monolayers, which were characterised by zeta potential measurements and Langmuir isotherms respectively. A combination of increased lysyl-phosphatidylglycerol content and mild environmental acidity were found to synergistically neutralise the charge of the membranes, in one instance altering the zeta potential from -56mV to +21mV, and induce closer packing between the lipids. Challenge of reconstituted S. aureus lipid model membranes by the antimicrobial peptide magainin 2 F5W was examined using monolayer subphase injection and neutron diffraction, and revealed that ionisation of the headgroup α-amine of lysyl-phosphatidylglycerol at pH 5.5, which reduced the magnitude of the peptide-lipid interaction by 80%, was more important for resisting peptide partitioning than increased lipid content alone. The significance of these results is discussed in relation to how colonising mildly acidic environments such as human mucosa may be facilitated by increased lysyl-phosphatidylglycerol biosynthesis and the implications of this for further biophysical analysis of the role of this lipid in bacterial membranes.

3 September 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMuhammad Umair Amin
Muhammad Umair Amin
SASajid Ali
Sajid Ali
Imran TariqImran Tariq
Imran Tariq
MAMuhammad Yasir Ali
Muhammad Yasir Ali
SPShashank Reddy Pinnapireddy
Shashank Reddy Pinnapireddy
Udo BakowskyUdo Bakowsky
Udo Bakowsky
The immediate release of chemotherapeutics at the target site, along with no premature release in circulation is always challenging. The purpose of this study was to develop a stimuli responsive drug delivery system, composed of lipid supported mesoporous silica nanoparticles (MSNPs) for triggered drug release at the target site and simultaneously avoiding the premature release. MSNPs with a higher drug loading capacity and very slow release were designed so as to enhance release by FDA approved US-irradiation. Doxorubicin, as a model drug, and perfluoropentane (PFP) as a US responsive material, were entrapped in the porous structure of MSNPs. Lipid coating enhanced the cellular uptake and in addition provided a gatekeeping effect at the pore opening to reduce premature release. The mechanical and thermal effects of US induced the conversion of liquid PFP to a gaseous form that was able to rupture the lipid layer, resulting in triggered drug release. The prolonged stability profile and non-toxic behavior made them suitable candidate for the delivery of anticancer drugs. This smart system, with the abilities of better cellular uptake and higher cytotoxic effects on US-irradiation, would be a good addition to the applied side of chemotherapeutic advanced drug delivery systems.

1 November 2019 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
OPOlivia Pabois
Olivia Pabois
CLChristian D. Lorenz
Christian D. Lorenz
RHRichard D Harvey
Richard D Harvey
IGIsabelle Grillo
Isabelle Grillo
MGMyriam Grundy
Myriam Grundy
CDCecile Dreiss
Cecile Dreiss